Huron Consulting Group (NASDAQ:HURN) Issues FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN - Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 6.800-7.600 for the period, compared to the consensus EPS estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Benchmark increased their price target on Huron Consulting Group from $140.00 to $165.00 and gave the company a "buy" rating in a report on Wednesday. William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday. Barrington Research increased their price target on Huron Consulting Group from $142.00 to $167.00 and gave the company an "outperform" rating in a report on Thursday. Wedbush assumed coverage on Huron Consulting Group in a report on Monday, February 3rd. They set an "outperform" rating on the stock. Finally, Truist Financial reissued a "buy" rating and set a $165.00 price target (up from $140.00) on shares of Huron Consulting Group in a report on Wednesday. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $151.75.

Huron Consulting Group Stock Performance

Shares of NASDAQ:HURN traded up $2.88 during midday trading on Friday, hitting $152.46. The company had a trading volume of 243,800 shares, compared to its average volume of 133,049. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market cap of $2.70 billion, a price-to-earnings ratio of 33.14 and a beta of 0.59. Huron Consulting Group has a 12-month low of $84.26 and a 12-month high of $153.77. The company has a fifty day moving average of $127.53 and a two-hundred day moving average of $118.15.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping the consensus estimate of $1.52 by $0.38. The firm had revenue of $399.31 million during the quarter, compared to analyst estimates of $380.62 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. On average, equities research analysts expect that Huron Consulting Group will post 6.1 EPS for the current fiscal year.

Insider Transactions at Huron Consulting Group

In other Huron Consulting Group news, Director James H. Roth sold 2,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $123.70, for a total value of $247,400.00. Following the completion of the sale, the director now owns 52,825 shares in the company, valued at approximately $6,534,452.50. This represents a 3.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director H Eugene Lockhart sold 12,500 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $150.00, for a total value of $1,875,000.00. Following the completion of the sale, the director now owns 12,172 shares of the company's stock, valued at $1,825,800. The trade was a 50.66 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 21,084 shares of company stock worth $2,942,539 in the last three months. Corporate insiders own 2.02% of the company's stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.